Back to Trades
Landis G. Michael
Chief Financial OfficerDirectorCIK 0001548560
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Landis G. Michael, Chief Financial Officer, Director, has filed 2 SEC reports (2026), all concentrated in Polaryx Therapeutics, Inc. (PLYX), totaling $8.0K in disclosed volume. Weighing $8.0K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $8.0K in Polaryx Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 20 | PLYX Polaryx Therapeutics, Inc. | Landis G. Michael | Chief Financial Officer, Director | Buy | $8.0K |
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | Landis G. Michael | Chief Financial Officer, Director | Other | $0 |
2 filings